Literature DB >> 18674887

Dynamic changes of the endogenous cannabinoid and opioid mesocorticolimbic systems during adolescence: THC effects.

M Ellgren1, A Artmann, O Tkalych, A Gupta, H S Hansen, S H Hansen, L A Devi, Y L Hurd.   

Abstract

Adolescence is a critical phase of active brain development often characterized by the initiation of marijuana (Cannabis sativa) use. Limited information is known regarding the endogenous cannabinoid system of the adolescent brain as well as related neurotransmitters that appear sensitive to cannabis exposure. We recently observed that adult rats pre-exposed to Delta-9-tetrahydrocannabinol (THC) during adolescence self-administered higher amounts of heroin and had selective impairments of the enkephalin opioid system within the nucleus accumbens (NAc) implicated in reward-related behavior. To explore the ontogeny of the cannabinoid and opioid neuronal systems in association with adolescence THC exposure, rats were examined at different adolescent stages during an intermittent THC paradigm (1.5 mg/kg i.p. every third day) from postnatal days (PNDs) 28-49. Rat brains were examined 24 h after injection at PND 29 (early adolescence), PND 38 (mid adolescence) and PND 50 (late adolescence) and analyzed for endocannabinoids (anandamide and 2-arachidonoylglycerol), Met-enkephalin, cannabinoid CB(1) receptors and micro opioid receptors (microOR) in the NAc, caudate-putamen and prefrontal cortex (PFC). Of the markers studied, the endocannabinoid levels had the most robust alterations throughout adolescence and were specific to the PFC and NAc. Normal correlations between anandamide and 2-arachidonoylglycerol concentrations in the NAc (positive) and PFC (negative) were reversed by THC. Other significant THC-induced effects were confined to the NAc - increased anandamide, decreased Met-enkephalin and decreased microORs. These findings emphasize the dynamic nature of the mesocorticolimbic endocannabinoid system during adolescence and the selective mesocorticolimbic disturbance as a consequence of adolescent cannabis exposure.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18674887      PMCID: PMC2745315          DOI: 10.1016/j.euroneuro.2008.06.009

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  59 in total

1.  Postnatal development of mu-opioid receptors in the rat caudate-putamen nucleus parallels asymmetric synapse formation.

Authors:  H Wang; V C Cuzon; V M Pickel
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

Review 2.  Trajectories of brain development: point of vulnerability or window of opportunity?

Authors:  Susan L Andersen
Journal:  Neurosci Biobehav Rev       Date:  2003 Jan-Mar       Impact factor: 8.989

3.  Compartment-specific localization of cannabinoid 1 (CB1) and mu-opioid receptors in rat nucleus accumbens.

Authors:  V M Pickel; J Chan; T L Kash; J J Rodríguez; K MacKie
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

4.  Limbic and motor circuitry underlying footshock-induced reinstatement of cocaine-seeking behavior.

Authors:  Krista McFarland; Susan B Davidge; Christopher C Lapish; Peter W Kalivas
Journal:  J Neurosci       Date:  2004-02-18       Impact factor: 6.167

5.  Cannabis dependence and psychotic symptoms in young people.

Authors:  D M Fergusson; L J Horwood; N R Swain-Campbell
Journal:  Psychol Med       Date:  2003-01       Impact factor: 7.723

6.  Defective adult neurogenesis in CB1 cannabinoid receptor knockout mice.

Authors:  Kunlin Jin; Lin Xie; Sun Hee Kim; Sophie Parmentier-Batteur; Yunjuan Sun; Xiao Ou Mao; Jocelyn Childs; David A Greenberg
Journal:  Mol Pharmacol       Date:  2004-08       Impact factor: 4.436

7.  Differential diurnal variations of anandamide and 2-arachidonoyl-glycerol levels in rat brain.

Authors:  M Valenti; D Viganò; M G Casico; T Rubino; L Steardo; D Parolaro; V Di Marzo
Journal:  Cell Mol Life Sci       Date:  2004-04       Impact factor: 9.261

8.  Cannabis use and age at onset of schizophrenia.

Authors:  Natalie D Veen; Jean-Paul Selten; Ingeborg van der Tweel; Wilma G Feller; Hans W Hoek; René S Kahn
Journal:  Am J Psychiatry       Date:  2004-03       Impact factor: 18.112

9.  First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol.

Authors:  Alan I Green; Mauricio F Tohen; Robert M Hamer; Stephen M Strakowski; Jeffrey A Lieberman; Ira Glick; W Scott Clark
Journal:  Schizophr Res       Date:  2004-02-01       Impact factor: 4.939

10.  Analysis of endocannabinoids by Ag+ coordination tandem mass spectrometry.

Authors:  Philip J Kingsley; Lawrence J Marnett
Journal:  Anal Biochem       Date:  2003-03-01       Impact factor: 3.365

View more
  73 in total

1.  Cannabinoid CB1 receptor inhibition blunts adolescent-typical increased binge alcohol and sucrose consumption in male C57BL/6J mice.

Authors:  Abigail E Agoglia; Sarah E Holstein; Vallari R Eastman; Clyde W Hodge
Journal:  Pharmacol Biochem Behav       Date:  2016-01-19       Impact factor: 3.533

2.  Impact of ADHD and cannabis use on executive functioning in young adults.

Authors:  Leanne Tamm; Jeffery N Epstein; Krista M Lisdahl; Brooke Molina; Susan Tapert; Stephen P Hinshaw; L Eugene Arnold; Katerina Velanova; Howard Abikoff; James M Swanson
Journal:  Drug Alcohol Depend       Date:  2013-08-11       Impact factor: 4.492

3.  The association between alcohol use trajectories from adolescence to adulthood and cannabis use disorder in adulthood: a 22-year longitudinal study.

Authors:  Jung Yeon Lee; Judith S Brook; Mario De La Rosa; Youngjin Kim; David W Brook
Journal:  Am J Drug Alcohol Abuse       Date:  2017-03-01       Impact factor: 3.829

Review 4.  Neural substrates underlying the negative impact of cannabinoid exposure during adolescence.

Authors:  Hanna M Molla; Kuei Y Tseng
Journal:  Pharmacol Biochem Behav       Date:  2020-06-09       Impact factor: 3.533

Review 5.  Cannabis and the Developing Brain: Insights into Its Long-Lasting Effects.

Authors:  Yasmin L Hurd; Olivier J Manzoni; Mikhail V Pletnikov; Francis S Lee; Sagnik Bhattacharyya; Miriam Melis
Journal:  J Neurosci       Date:  2019-10-16       Impact factor: 6.167

6.  Δ9-Tetrahydrocannabinol changes the brain lipidome and transcriptome differentially in the adolescent and the adult.

Authors:  Emma Leishman; Michelle Murphy; Ken Mackie; Heather B Bradshaw
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-02-08       Impact factor: 4.698

Review 7.  Neurobiological consequences of maternal cannabis on human fetal development and its neuropsychiatric outcome.

Authors:  Didier Jutras-Aswad; Jennifer A DiNieri; Tibor Harkany; Yasmin L Hurd
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-07-02       Impact factor: 5.270

Review 8.  The Role of the Endocannabinoid System and Genetic Variation in Adolescent Brain Development.

Authors:  Heidi C Meyer; Francis S Lee; Dylan G Gee
Journal:  Neuropsychopharmacology       Date:  2017-07-07       Impact factor: 7.853

9.  Adolescent Δ(9)-Tetrahydrocannabinol Exposure Alters WIN55,212-2 Self-Administration in Adult Rats.

Authors:  Maria Scherma; Christian Dessì; Anna Lisa Muntoni; Salvatore Lecca; Valentina Satta; Antonio Luchicchi; Marco Pistis; Leigh V Panlilio; Liana Fattore; Steven R Goldberg; Walter Fratta; Paola Fadda
Journal:  Neuropsychopharmacology       Date:  2015-09-21       Impact factor: 7.853

10.  Reward sensitivity for a palatable food reward peaks during pubertal developmental in rats.

Authors:  Chris M Friemel; Rainer Spanagel; Miriam Schneider
Journal:  Front Behav Neurosci       Date:  2010-07-13       Impact factor: 3.558

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.